Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Drug Design and Discovery|November 1, 1994
Molecular modelling of CCK-A receptorsA Van Der Bent, A P Ijzerman, W SoudijnJournal of Medicinal Chemistry|February 21, 1992
A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptorE M van der Wenden, A P Ijzerman, W SoudijnBiochemical and Biophysical Research Communications|September 15, 1983
Purification and characterization of enkephalin-degradating enzymes from calf-brain striatumJ G van Amsterdam, K J van Buuren, W SoudijnEuropean Journal of Pharmacology|August 15, 1978
Regional localization of halopemide, a new psychotropic agent, in the rat brainA J Loonen, I van Wijngaarden, P A Janssen, et al.European Journal of Pharmacology|January 1, 1994
Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016M W Beukers, C J Kerkhof, A P IJzerman, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Functional characteristics of a series of N4-substituted 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazines as 5-HT1A receptor ligands. Structure-activity relationshipsB J van Steen, I van Wijngaarden, E Ronken, et al.European Journal of Pharmacology|October 1, 1977
The regional localisation of a new potent centrally acting antihypertensive agent R 28935 and its less active threo-isomer R29814 in the cat brainA J Loonen, W Soudijn, H H Van Rooy, et al.Journal of Medicinal Chemistry|August 19, 1994
Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituentsB J van Steen, I van Wijngaarden, M T Tulp, et al.British Journal of Pharmacology|February 1, 1995
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive ratsR A Mathôt, A Cleton, W Soudijn, et al.Journal of Medicinal Chemistry|October 13, 1995
A series of N4-imidoethyl derivatives of 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1A receptor ligands: synthesis and structure-affinity relationshipsB J van Steen, I van Wijngaarden, M T Tulp, et al.Pageof 7